Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Oct 25;13:925377. doi: 10.3389/fphar.2022.925377

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 Yang, Lv, Yu, Mei, Xiang, Zhao and Li.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Neoplasm reporting rate of GLP-1RA and DPP4i combination therapy. The reporting rates of GLP-1RA-associated neoplasms were compared with different comparators in “GLP-1RA vs. GLD”: other glucose-lowering drugs when the indication is limited to diabetes while excluding all tumors and in “GLP-1RA + DPP4i vs. GLD + DPP4i”: only the cases in combination with DPP4i on the basis of “GLP-1RA vs. GLD” for comparison were selected.